Literature DB >> 1434035

[Clinical significance of the measurement of serum pepsinogen group I and II by enzyme-linked immunosorbent assay].

K Matsumoto1, K Hashimoto, T Samori, M Taniguchi, K Kotera, S Nishi, M Takatsuji, K Higashi, K Itoh.   

Abstract

We have developed enzyme-linked immunosorbent assay (ELISA) for pepsinogen group I and II (PG I.II) in human serum, and clinical significance of serum pepsinogen measurement was evaluated. Serum PG I.II levels in patients with gastric and duodenal ulcer were higher than those in normal healthy subjects. On the other hand, serum PG I levels in patients with pernicious anemia were significantly low levels. In both gastric ulcer and duodenal ulcer, serum PG I.II levels at active stage were higher than healing stage. These results suggested that the measurement of PG I.II levels was useful for screening or monitoring test for the injury of gastric and duodenal mucosa.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1434035

Source DB:  PubMed          Journal:  Rinsho Byori        ISSN: 0047-1860


  1 in total

1.  Accuracy of screening for gastric cancer using serum pepsinogen concentrations.

Authors:  F Kitahara; K Kobayashi; T Sato; Y Kojima; T Araki; M A Fujino
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.